ExonHit Therapeutics Inc. Strengthens Its Intellectual Property Position in the US

PARIS--(BUSINESS WIRE)--Regulatory News: ExonHit (Paris:ALEHT) is pleased to announce that the United States Patent and Trademark Office (“USPTO”) notified the Company of its intent to issue a Re-examination Certificate in connection with ExonHit’s US Patent n° 6,881,571 directed to the use of its SpliceArray™ technology.
MORE ON THIS TOPIC